Huang CC and his colleagues determined the spectrum of FH genetic mutations in Taiwan in clinically diagnosed FH patients based on hyperlipidemia (LDL >190 mg/dL) and in those meeting the Taiwan FH diagnostic criteria (27). The gene discussed is FH; the disease is familial hyperaldosteronism.